Konstantin Chegaev

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

International journal of molecular sciences

Molecules (Basel, Switzerland)

Antioxidants (Basel, Switzerland)

Molecular pharmaceutics

Universita degli Studi di Torino Dipartimento di Scienza e Tecnologia del Farmaco (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Universita degli Studi di Torino Dipartimento di Scienza e Tecnologia del Farmaco Nov 02 2001

Italy

PHD

Publications

Galina A Gazieva, Konstantin Chegaev
Special Issue "Development and Synthesis of Biologically Active Compounds". International journal of molecular sciences 25 (7) (2024)
Galina A Gazieva, Konstantin Chegaev
Special Issue "Development and Synthesis of Biologically Active Compounds". International journal of molecular sciences 25 (7) (2024)
Galina A Gazieva, Konstantin Chegaev
Special Issue "Development and Synthesis of Biologically Active Compounds". International journal of molecular sciences 25 (7) (2024)
Elisabetta Marini, Barbara Rolando, Federica Sodano, Federica Blua, Giulia Concina, Stefano Guglielmo, Loretta Lazzarato, Konstantin Chegaev
Comparative Study of Different H 2 S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Federica Sodano, Barbara Rolando, Loretta Lazzarato, Costanzo Costamagna, Mariacristina Failla, Chiara Riganti, Konstantin Chegaev
Use of Enzymatically Activated Carbon Monoxide Donors for Sensitizing Drug-Resistant Tumor Cells. International journal of molecular sciences 24 (14) (2023)
Elisabetta Marini, Barbara Rolando, Federica Sodano, Federica Blua, Giulia Concina, Stefano Guglielmo, Loretta Lazzarato, Konstantin Chegaev
Comparative Study of Different H 2 S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Elisabetta Marini, Barbara Rolando, Federica Sodano, Federica Blua, Giulia Concina, Stefano Guglielmo, Loretta Lazzarato, Konstantin Chegaev
Comparative Study of Different H 2 S Donors as Vasodilators and Attenuators of Superoxide-Induced Endothelial Damage. Antioxidants (Basel, Switzerland) 12 (2) (2023)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Elisabetta Marini, Marta Giorgis, Marta Leporati, Barbara Rolando, Konstantin Chegaev, Loretta Lazzarato, Massimo Bertinaria, Marco Vincenti, Antonella Di Stilo
Multitarget Antioxidant NO-Donor Organic Nitrates: A Novel Approach to Overcome Nitrates Tolerance, an Ex Vivo Study. Antioxidants (Basel, Switzerland) 11 (1) (2022)
Elena Peira, Daniela Chirio, Simona Sapino, Konstantin Chegaev, Giulia Chindamo, Iris Chiara Salaroglio, Chiara Riganti, Marina Gallarate
Naked and Decorated Nanoparticles Containing H 2 S-Releasing Doxorubicin: Preparation, Characterization and Assessment of Their Antitumoral Efficiency on Various Resistant Tumor Cells. International journal of molecular sciences 23 (19) (2022)
Eleonora Gianquinto, Federica Sodano, Barbara Rolando, Magdalena Kostrzewa, Marco Allarà, Ali Mokhtar Mahmoud, Poulami Kumar, Francesca Spyrakis, Alessia Ligresti, Konstantin Chegaev
N -[1,3-Dialkyl(aryl)-2-oxoimidazolidin-4-ylidene]-aryl(alkyl)sulphonamides as Novel Selective Human Cannabinoid Type 2 Receptor (hCB2R) Ligands; Insights into the Mechanism of Receptor Activation/Deactivation. Molecules (Basel, Switzerland) 27 (23) (2022)
Aurore Fraix, Cristina Parisi, Mariacristina Failla, Konstantin Chegaev, Francesca Spyrakis, Loretta Lazzarato, Roberta Fruttero, Alberto Gasco, Salvatore Sortino
NO release regulated by doxorubicin as the green light-harvesting antenna. Chemical communications (Cambridge, England) 56 (47) (2021)
Federica Sodano, Loretta Lazzarato, Barbara Rolando, Francesca Spyrakis, Carmen De Caro, Salvatore Magliocca, Domenica Marabello, Konstantin Chegaev, Elena Gazzano, Chiara Riganti, Antonio Calignano, Roberto Russo, Maria Grazia Rimoli
Paracetamol-Galactose Conjugate: A Novel Prodrug for an Old Analgesic Drug. Molecular pharmaceutics 16 (10) (2019)
Salvatore Magliocca, Carmen De Caro, Loretta Lazzarato, Roberto Russo, Barbara Rolando, Konstantin Chegaev, Elisabetta Marini, Maria Nieddu, Lucia Burrai, Gianpiero Boatto, Claudia Cristiano, Domenica Marabello, Elena Gazzano, Chiara Riganti, Federica Sodano, Maria Grazia Rimoli
Aceclofenac-Galactose Conjugate: Design, Synthesis, Characterization, and Pharmacological and Toxicological Evaluations. Molecular pharmaceutics 15 (8) (2018)
Marialessandra Contino, Stefano Guglielmo, Maria Grazia Perrone, Roberta Giampietro, Barbara Rolando, Antonio Carrieri, Daniele Zaccaria, Konstantin Chegaev, Vanessa Borio, Chiara Riganti, Katarzyna Zabielska-Koczywąs, Nicola Antonio Colabufo, Roberta Fruttero
New tetrahydroisoquinoline-based P-glycoprotein modulators: decoration of the biphenyl core gives selective ligands. MedChemComm 9 (5) (2018)
Iris Chiara Salaroglio, Elena Gazzano, Joanna Kopecka, Konstantin Chegaev, Costanzo Costamagna, Roberta Fruttero, Stefano Guglielmo, Chiara Riganti
New Tetrahydroisoquinoline Derivatives Overcome Pgp Activity in Brain-Blood Barrier and Glioblastoma Multiforme in Vitro. Molecules (Basel, Switzerland) 23 (6) (2018)
Guilherme Felipe Dos Santos Fernandes, Paula Carolina de Souza, Elsa Moreno-Viguri, Mery Santivañez-Veliz, Rocio Paucar, Silvia Pérez-Silanes, Konstantin Chegaev, Stefano Guglielmo, Loretta Lazzarato, Roberta Fruttero, Chung Man Chin, Patricia Bento da Silva, Marlus Chorilli, Mariana Cristina Solcia, Camila Maríngolo Ribeiro, Caio Sander Paiva Silva, Leonardo Biancolino Marino, Priscila Longhin Bosquesi, Debbie M Hunt, Luiz Pedro S de Carvalho, Carlos Alberto de Souza Costa, Sang Hyun Cho, Yuehong Wang, Scott Gary Franzblau, Fernando Rogério Pavan, Jean Leandro Dos Santos
Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity. Journal of medicinal chemistry 60 (20) (2017)
Francesca Di Guida, Claudio Pirozzi, Salvatore Magliocca, Anna Santoro, Adriano Lama, Roberto Russo, Maria Nieddu, Lucia Burrai, Gianpiero Boatto, Maria Pina Mollica, Federica Sodano, Loretta Lazzarato, Konstantin Chegaev, Rosaria Meli, Giuseppina Mattace Raso, Maria Grazia Rimoli
Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis. Molecular pharmaceutics 15 (1) (2017)

Konstantin Chegaev.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Konstantin Chegaev